HeartBeam Reports Partnership With Triple Ring Technologies To Co Develop Telehealth Solution Device, No Terms Disclosed
3D Vector ECG Collection Device Slated for FDA 510k Submission in the Fourth Quarter of 2022
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ:BEAT), a developmental stage digital healthcare company with a